Cambridge Investment Research Advisors, Inc. Surmodics Inc Transaction History

Cambridge Investment Research Advisors, Inc.

$29.4 Billion
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Jul 13, 2022	SELL	$33.25 - $45.11 $158,935 - $215,625	-4,780 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$52.8 - $60.32 $252,384 - $288,329	4,780 New	4,780 $265,000

Others Institutions Holding SRDX

# of Institutions

126

Shares Held

11.7M

Call Options Held

1.4K

Put Options Held

8.6K

Black Rock Inc. New York, NY

1.17M
Shares

$44.6 Million
0.0% of portfolio
Alliancebernstein L.P. New York, NY

1.04M
Shares

$39.6 Million
0.01% of portfolio
Beryl Capital Management LLC Redondo Beach, CA

989K
Shares

$37.7 Million
14.09% of portfolio
Vanguard Group Inc Valley Forge, PA

804K
Shares

$30.6 Million
0.0% of portfolio
Morgan Stanley New York, NY

753K
Shares

$28.7 Million
0.0% of portfolio

View Full List

About SURMODICS INC

Ticker SRDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 14,005,000
Market Cap $533M
Description
Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...

More about SRDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account